Katharine Collins

Katharine is a Senior Program Officer in the Science and Global Health R&D Fund, where she manages a portfolio of grants covering malaria, Strep A, vaccine and adjuvant development, and vaccine delivery.

Before joining Coefficient Giving in 2023, Katharine spent nearly two decades as an international malaria researcher, holding positions at the University of Oxford in the UK, QIMR in Australia, and RUMC in the Netherlands. Her work spanned the translational research pipeline—from early vaccine design and development to clinical evaluation in malaria-endemic settings, with various projects in Burkina Faso, Kenya, The Gambia, and Mali.

Katharine co-invented the R21/Matrix-M malaria vaccine, now being rolled out in Africa. She also developed novel controlled human malaria infection models to accelerate vaccine and drug testing and led research to better understand malaria transmission dynamics. She holds a PhD in malaria vaccine development from the University of Oxford and a master’s degree in molecular and cellular biology from the University of Bath.